Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (2): 131-135.doi: 10.6040/j.issn.1673-3770.0.2020.206
Previous Articles Next Articles
ZHANG Yiyi1Overview,XUE Gang2, JIN Chunting3Guidance
CLC Number:
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. doi:10.3322/caac.21492. [2] Cabanillas ME, McFadden DG, Durante C. Thyroid cancer[J]. Lancet, 2016, 388(10061):2783-2795. doi:10.1016/s0140-6736(16)30172-6. [3] Kitahara CM, Sosa JA. The changing incidence of thyroid cancer[J]. Nat Rev Endocrinol, 2016, 12(11):646-653. doi:10.1038/nrendo.2016.110. [4] Li N, Du XL, Reitzel LR, et al. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008[J]. Thyroid, 2013, 23(1):103-110. doi:10.1089/thy.2012.0392. [5] 邱杰, 孙彦. 肿瘤标志物检测在甲状腺癌临床诊治中的意义[J]. 山东大学耳鼻喉眼学报, 2016, 30(2):28-31. doi:10.6040/j.issn.1673-3770.1.2016.08. QIU Jie, SUN Yan. Role of tumor marker in the diagnosis and treatment of thyroid carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(2):28-31. doi:10.6040/j.issn.1673-3770.1.2016.08. [6] Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review[J]. Endocr Relat Cancer, 2015, 22(3):R157-R164. doi:10.1530/erc-15-0156. [7] Rajagopal C, Harikumar KB. The origin and functions of exosomes in cancer[J]. Front Oncol, 2018, 8:66. doi:10.3389/fonc.2018.00066. [8] Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles[J]. Trends Cell Biol, 2017, 27(3):172-188. doi:10.1016/j.tcb.2016.11.003. [9] Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release[J]. Cell Mol Life Sci, 2018, 75(2):193-208. doi:10.1007/s00018-017-2595-9. [10] Kalluri R. The biology and function of exosomes in cancer[J]. J Clin Invest, 2016, 126(4):1208-1215. doi:10.1172/jci81135. [11] Zhang H, Freitas D, Kim HS, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation[J]. Nat Cell Biol, 2018, 20(3):332-343. doi:10.1038/s41556-018-0040-4. [12] Wen SW, Lima LG, Lobb RJ, et al. Breast cancer-derived exosomes reflect the cell-of-origin phenotype[J]. Proteomics, 2019, 19(8):e1800180. doi:10.1002/pmic.201800180. [13] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478)DOI:10.1126/science.aau6977. doi:10.1126/science.aau6977. [14] Zhao L, Yu J, Wang J, et al. Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients[J]. J Cancer, 2017, 8(7):1145-1152. doi:10.7150/jca.18026. [15] 叶枫, 董惠芬, 刘镕. 外泌体分离方法的研究进展[J]. 中国病原生物学杂志, 2019, 14(1):118-122. doi:10.13350/j.cjpb.190126. YE Feng, DONG Huifen, LIU Rong. Comparison of methods of isolating exosomes[J]. Journal of Pathogen Biology, 2019, 14(1):118-122. doi:10.13350/j.cjpb.190126. [16] Welton JL, Khanna S, Giles PJ, et al. Proteomics analysis of bladder cancer exosomes[J]. Mol Cell Proteomics, 2010, 9(6):1324-1338. doi:10.1074/mcp.m000063-mcp201. [17] Koritzinsky EH, Street JM, Star RA, et al. Quantification of exosomes[J]. J Cell Physiol, 2017, 232(7):1587-1590. doi:10.1002/jcp.25387. [18] Stoltenburg R, Reinemann C, Strehlitz B. SELEX: a(r)evolutionary method to generate high-affinity nucleic acid ligands[J]. Biomol Eng, 2007, 24(4):381-403. doi:10.1016/j.bioeng.2007.06.001. [19] 吴金恩, 丁军涛. 外泌体生物学功能及应用研究进展[J]. 动物医学进展, 2016, 37(12):90-94. doi:10.16437/j.cnki.1007-5038.2016.12.018. WU Jin'en, DING Juntao. Progress on biological function and application of exosomes[J]. Progress in Veterinary Medicine, 2016, 37(12):90-94. doi:10.16437/j.cnki.1007-5038.2016.12.018. [20] Liu Y, Luo F, Wang B, et al. STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells[J]. Cancer Lett, 2016, 370(1):125-135. doi:10.1016/j.canlet.2015.10.011. [21] Clark DJ, Fondrie WE, Yang A, et al. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes[J]. J Proteomics, 2016, 133:161-169. doi:10.1016/j.jprot.2015.12.023. [22] Yang WW, Yang LQ, Zhao F, et al. Epiregulin promotes lung metastasis of salivary adenoid cystic carcinoma[J]. Theranostics, 2017, 7(15):3700-3714. doi:10.7150/thno.19712. [23] 周昌娈, 谭磊, 丁铲. RNA病毒利用外泌体促进病毒感染的研究进展[J]. 微生物学通报, 2017, 44(12):2988-2996. doi:10.13344/j.microbiol.china.170390. ZHOU Changluan, TAN Lei, DING Chan. Advances of RNA virus increasing viral infection through the exosomes[J]. Microbiology, 2017, 44(12):2988-2996. doi:10.13344/j.microbiol.china.170390. [24] 魏晓晶, 胡晓. 外泌体功能与临床应用研究进展[J]. 中国医药导报, 2018, 15(34):45-48. WEI Xiaojing, HU Xiao. Advances in the study of function and clinical application of exosomes[J]. China Medical Herald, 2018, 15(34):45-48. [25] Pi F, Binzel DW, Lee TJ, et al. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression[J]. Nat Nanotechnol, 2018, 13(1):82-89. doi:10.1038/s41565-017-0012-z. [26] 贺丁冬, 冯艳林, 明心亮, 等. 外泌体源性非编码RNA作为肝癌标志物的研究进展[J]. 武汉大学学报(医学版), 2020, 41(2):255-259. doi:10.14188/j.1671-8852.2019.0577. HE Dingdong, FENG Yanlin, MING Xinliang, et al. Exosome-derived non-coding RNA as biomarkers in hepatocellular carcinoma diagnosis[J]. Medical Journal of Wuhan University, 2020, 41(2):255-259. doi:10.14188/j.1671-8852.2019.0577. [27] Shi X, Wang B, Feng X, et al. circRNAs and exosomes: a mysterious frontier for human cancer[J]. Mol Ther Nucleic Acids, 2020, 19:384-392. doi:10.1016/j.omtn.2019.11.023. [28] Tai YL, Chen KC, Hsieh JT, et al. Exosomes in cancer development and clinical applications[J]. Cancer Sci, 2018, 109(8):2364-2374. doi:10.1111/cas.13697. [29] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478). doi:10.1126/science.aau6977. [30] Wu G, Zhou W, Lin X, et al. circRASSF2 Acts as CeRNA and promotes papillary thyroid carcinoma progression through miR-1178/TLR4 signaling pathway[J]. Mol Ther Nucleic Acids, 2020, 19:1153-1163. doi:10.1016/j.omtn.2019.11.037. [31] Wu G, Zhou W, Pan X, et al. Circular RNA profiling reveals exosomal circ_0006156 as a novel biomarker in papillary thyroid cancer[J]. Mol Ther Nucleic Acids, 2020, 19:1134-1144. doi:10.1016/j.omtn.2019.12.025. [32] Ye W, Deng X, Fan Y. Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy[J]. Neoplasma, 2019, 66(4):516-523. doi:10.4149/neo_2018_180824n643. [33] Wu Q, Sun S, Li Z, et al. Tumour-originated exosomal miR-155 triggers cancer-associated Cachexia to promote tumour progression[J]. Mol Cancer, 2018, 17(1):155. doi:10.1186/s12943-018-0899-5. [34] Kalluri R. The biology and function of exosomes in cancer[J]. J Clin Investig, 2016, 126(4):1208-1215. doi:10.1172/jci81135. [35] Wang M, Chen B, Ru Z, et al. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway[J]. Biochem Biophys Res Commun, 2018, 504(1):283-288. doi:10.1016/j.bbrc.2018.08.175. [36] Lee JC, Zhao JT, Gundara J, et al. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222[J]. J Surg Res, 2015, 196(1):39-48. doi:10.1016/j.jss.2015.02.027. [37] Zhu LY, Gangadaran P, Kalimuthu S, et al. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells[J]. Artif Cells Nanomed Biotechnol, 2018, 46(sup3):S166-S179. doi:10.1080/21691401.2018.1489824. [38] Samsonov R, Burdakov V, Shtam T, et al. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer[J]. Tumour Biol, 2016, 37(9):12011-12021. doi:10.1007/s13277-016-5065-3. [39] Jiang K, Li GP, Chen WJ, et al. Plasma exosomal miR-146b-5p and miR-222-3p are potential biomarkers for lymph node metastasis in papillary thyroid carcinomas[J]. Oncotargets Ther, 2020, 13:1311-1319. doi:10.2147/ott.s231361. [40] Liang MH, Yu SM, Tang SL, et al. A panel of plasma exosomal miRNAs as potential biomarkers for differential diagnosis of thyroid nodules[J]. Front Genet, 2020, 11:449. doi:10.3389/fgene.2020.00449. [41] Dai D, Tan Y, Guo L, et al. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing[J]. Eur J Endocrinol, 2020, 182(1):111-121. doi:10.1530/eje-19-0524. [42] Yang C, Wei Y, Yu L, et al. Identification of altered circular RNA expression in serum exosomes from patients with papillary thyroid carcinoma by high-throughput sequencing[J]. Med Sci Monit, 2019, 25:2785-2791. doi:10.12659/msm.915658. |
[1] | ZHANG Xuping, LIU Xuexia,ZHANG Hua. Current progress of exosome research in allergic diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(2): 136-140. |
[2] | BIAN Xiaomin, HAN Guanghong, YU Dan. Recent advances regarding extracellular vesicles in head and neck cancers [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 99-104. |
[3] | ZOU Liangyu, LI Lianhe, YUE Wenhui, HAN Zhipeng, ZHANG Zihui. Clinical significance and correlation between MIF and GSK-3β expression in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 76-80. |
[4] | ZHOU Wencheng, YUAN Yuan, CHENG Lei. Predictive biomarkers for dust mite specific immunotherapy in patients with allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 43-49. |
|